SEC Form 5 · accession 0001209191-16-093244
Insys Therapeutics, Inc. · INSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darryl S Baker
Officer — Chief Financial Officer
Period of report
Dec 31, 2015
Accepted (ET)
Jan 22, 2016 · 5:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 20, 2015 | G | 9,000 | $0.00 | D | 11,030 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 5, 2015, the Issuer effected a 2-for-1 stock split, resulting in the reporting person's ownership of 9,377 additional shares of common stock.
- F2Includes 1,276 shares acquired by the Reporting Person on June 10, 2015 pursuant to the Issuer's Employer Stock Purchase Plan.